312 related articles for article (PubMed ID: 9765514)
1. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
Kovoor A; Celver JP; Wu A; Chavkin C
Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514
[TBL] [Abstract][Full Text] [Related]
2. Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes.
Celver JP; Lowe J; Kovoor A; Gurevich VV; Chavkin C
J Biol Chem; 2001 Feb; 276(7):4894-900. PubMed ID: 11060299
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
Li AH; Wang HL
J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
[TBL] [Abstract][Full Text] [Related]
4. Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin.
Appleyard SM; Celver J; Pineda V; Kovoor A; Wayman GA; Chavkin C
J Biol Chem; 1999 Aug; 274(34):23802-7. PubMed ID: 10446141
[TBL] [Abstract][Full Text] [Related]
5. Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes.
Kovoor A; Nappey V; Kieffer BL; Chavkin C
J Biol Chem; 1997 Oct; 272(44):27605-11. PubMed ID: 9346897
[TBL] [Abstract][Full Text] [Related]
6. mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin.
Lowe JD; Celver JP; Gurevich VV; Chavkin C
J Biol Chem; 2002 May; 277(18):15729-35. PubMed ID: 11861651
[TBL] [Abstract][Full Text] [Related]
7. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
Chakrabarti S; Law PY; Loh HH
J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
[TBL] [Abstract][Full Text] [Related]
8. Distinct domains of the mu-opioid receptor control uncoupling and internalization.
Celver J; Xu M; Jin W; Lowe J; Chavkin C
Mol Pharmacol; 2004 Mar; 65(3):528-37. PubMed ID: 14978231
[TBL] [Abstract][Full Text] [Related]
9. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
Glück L; Loktev A; Moulédous L; Mollereau C; Law PY; Schulz S
Biol Psychiatry; 2014 Nov; 76(10):767-74. PubMed ID: 24629717
[TBL] [Abstract][Full Text] [Related]
10. Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide mu-opioid receptor agonists.
Blanchet C; Sollini M; Lüscher C
Mol Cell Neurosci; 2003 Oct; 24(2):517-23. PubMed ID: 14572471
[TBL] [Abstract][Full Text] [Related]
11. The role of the hydrophilic Asn230 residue of the mu-opioid receptor in the potency of various opioid agonists.
Pil J; Tytgat J
Br J Pharmacol; 2001 Oct; 134(3):496-506. PubMed ID: 11588103
[TBL] [Abstract][Full Text] [Related]
12. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy.
Hull LC; Llorente J; Gabra BH; Smith FL; Kelly E; Bailey C; Henderson G; Dewey WL
J Pharmacol Exp Ther; 2010 Mar; 332(3):1127-35. PubMed ID: 20008489
[TBL] [Abstract][Full Text] [Related]
13. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
[TBL] [Abstract][Full Text] [Related]
14. Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms.
Kuhar JR; Bedini A; Melief EJ; Chiu YC; Striegel HN; Chavkin C
Cell Signal; 2015 Sep; 27(9):1799-806. PubMed ID: 26056051
[TBL] [Abstract][Full Text] [Related]
15. G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.
Terman GW; Jin W; Cheong YP; Lowe J; Caron MG; Lefkowitz RJ; Chavkin C
Br J Pharmacol; 2004 Jan; 141(1):55-64. PubMed ID: 14662727
[TBL] [Abstract][Full Text] [Related]
16. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
17. Functional selectivity and time-dependence of μ-opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area.
Lowe JD; Bailey CP
Br J Pharmacol; 2015 Jan; 172(2):469-81. PubMed ID: 24467517
[TBL] [Abstract][Full Text] [Related]
18. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.
Lowe JD; Sanderson HS; Cooke AE; Ostovar M; Tsisanova E; Withey SL; Chavkin C; Husbands SM; Kelly E; Henderson G; Bailey CP
Mol Pharmacol; 2015 Aug; 88(2):347-56. PubMed ID: 26013542
[TBL] [Abstract][Full Text] [Related]
19. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
Mandyam CD; Thakker DR; Christensen JL; Standifer KM
J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
[TBL] [Abstract][Full Text] [Related]
20. A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization.
Wang HL
Neuropharmacology; 2000 Jan; 39(3):353-63. PubMed ID: 10698001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
